Quick Answer
KYNTRA BIO, INC. reported Total Assets of $119.59 million for fiscal year 2025.
KYNTRA BIO, INC. Total Assets — Annual History
| Fiscal Year | Total Assets | YoY Change |
|---|---|---|
| 2025 | $119.59M | -44.3% |
| 2024 | $214.53M | -49.3% |
| 2023 | $423.53M | -30.6% |
| 2022 | $610.09M | -21.2% |
| 2021 | $773.82M | -6.4% |
| 2020 | $826.84M | -3.6% |
| 2019 | $857.40M | -2.6% |
| 2018 | $880.60M | -2.0% |
| 2017 | $898.65M | +91.4% |
| 2016 | $469.55M | -0.2% |
| 2015 | $470.57M | -2.7% |
| 2014 | $483.53M | — |
Quarterly Total Assets
| Quarter Ending | Total Assets | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $137.01M | -48.2% | -23.0% |
| June 30, 2025 | $178.06M | -39.3% | +7.8% |
| March 31, 2025 | $165.21M | -54.8% | -23.0% |
| December 31, 2024 | $214.53M | -49.3% | -18.9% |
| September 30, 2024 | $264.42M | -42.6% | -9.8% |
| June 30, 2024 | $293.20M | -43.1% | -19.9% |
| March 31, 2024 | $365.87M | -32.1% | -13.6% |
| December 31, 2023 | $423.53M | -30.6% | -8.0% |
- KYNTRA BIO, INC. showed a decrease of -44.3% in Total Assets compared to the prior fiscal year.
- Over the 2014–2025 period, KYNTRA BIO, INC.’s total assets has declined by 75.3% (from $483.53 million to $119.59 million).
- The most recent figure is from KYNTRA BIO, INC.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 16, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: